Phase 1

Weight Loss with Naltrexone & BupropionDevelopment of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Sponsor:

Medical University of South Carolina

Code:

NCT07224087

Conditions

Obesity

Smoking Cessation

Bariatric Surgery Patients

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Naltrexone Hydrochloride

Bupropion HCl Extended Release

Cognitive-Behavioral Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Medical University of South Carolina on 2026-07-08.